E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 8/31/2006 in the Prospect News Biotech Daily.

Bausch & Lomb gets extension of waiver regarding any potential defaults

By Sara Rosenberg

New York, Aug. 31 - Bausch & Lomb Inc. received an extension of its credit facility waiver that was obtained as a precaution against any potential default, according to an 8-K filed with the Securities and Exchange Commission Thursday.

The waiver has been extended to Dec. 15 from Oct. 2.

As consideration for the extension, the company will pay a fee equal to 0.10% of its aggregate commitments to each lender that executed the amendment.

Payment of the monthly fee will be due on Oct. 3 and on the first day of each month thereafter that the company is delayed in filing its financial statements until the waiver termination date.

The waiver extension was completed on Aug. 28.

Bausch & Lomb is a Rochester, N.Y., developer, manufacturer and marketer of eye health products.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.